| Autor: |
Popat R; NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK., Augustson B; Sir Charles Gairdner Hospital and Linear Clinical Research, Perth, WA, Australia., Gironella M; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain., Lee C; Royal Adelaide Hospital, Adelaide, SA, Australia., Cannell P; Department of Haematology, Fiona Stanley Hospital, Perth, WA, Australia., Patel N; GSK, London, UK., Kasinathan RS; GSK, Upper Providence, PA, USA., Rogers R; GSK, Upper Providence, PA, USA., Shaikh M; GSK, London, UK., Curry A; GSK, Durham, NC, USA., Carreño F; GSK, Upper Providence, PA, USA., Roy-Ghanta S; GSK, Upper Providence, PA, USA., Opalinska J; GSK, Upper Providence, PA, USA., Quach H; University of Melbourne, St. Vincent's Hospital Melbourne, Melbourne, VIC, Australia. HANG.QUACH@svha.org.au. |
Full text from SpringerLink